Institutional Ownership Uro Gen Pharma Ltd. (URGN)
This table provides information about the institutional ownership of Uro Gen Pharma Ltd. (URGN). We have compiled data on the 161 institutions that hold shares in the stock, with a total of 39.6 Million shares, which have been reported (via 13F filing form) to have a value of $781 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Rtw Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
4,543,895
shares
|
$89.7 Million
0.96% of portfolio
|
Q2 2025
Added 18.49%
|
|
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
Aug 14, 2025 Q2 2025 |
3,190,510
shares
|
$63 Million
0.08% of portfolio
|
Q2 2025
Added 82.4%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
2,478,470
shares
|
$48.9 Million
0.0% of portfolio
|
Q2 2025
Added 188.96%
|
|
|
Jefferies Financial Group Inc.
New York, NY |
Aug 12, 2025 Q2 2025 |
2,199,652
shares
|
$43.4 Million
0.27% of portfolio
|
Q2 2025
Added 169.9%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,193,950
shares
|
$43.3 Million
0.0% of portfolio
|
Q2 2024
Added 27.79%
|
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
2,185,000
shares
|
$43.2 Million
2.32% of portfolio
|
Q2 2025
New holding
|
|
|
Silverarc Capital Management, LLC
|
Aug 14, 2025 Q2 2025 |
2,022,482
shares
|
$39.9 Million
6.7% of portfolio
|
Q2 2025
Added 46.43%
|
|
|
Acorn Capital Advisors, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
1,259,749
shares
|
$24.9 Million
11.29% of portfolio
|
Q2 2025
Reduced 16.92%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
1,200,000
shares
|
$23.7 Million
0.02% of portfolio
|
Q4 2023
Added 13.21%
|
|
|
Menora Mivtachim Holdings Ltd.
|
Aug 14, 2025 Q2 2025 |
1,152,531
shares
|
$22.8 Million
0.09% of portfolio
|
Q2 2025
Reduced 49.96%
|
|
|
Sg Americas Securities, LLC
|
Aug 08, 2025 Q2 2025 |
1,149,081
shares
|
$22.7 Million
0.07% of portfolio
|
Q2 2025
Added 607.07%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
1,000,000
shares
|
$19.8 Million
0.82% of portfolio
|
Q2 2025
New holding
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
830,000
shares
|
$16.4 Million
0.02% of portfolio
|
Q2 2025
Reduced 35.0%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
807,638
shares
|
$16 Million
0.0% of portfolio
|
Q2 2025
Added 1.59%
|
|
|
Migdal Insurance & Financial Holdings Ltd.
|
Aug 04, 2025 Q2 2025 |
770,909
shares
|
$15.2 Million
0.13% of portfolio
|
Q2 2025
Reduced 1.98%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Aug 14, 2025 Q2 2025 |
656,573
shares
|
$13 Million
1.07% of portfolio
|
Q2 2025
Added 2526.29%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
594,031
shares
|
$11.7 Million
0.0% of portfolio
|
Q2 2025
Added 40.24%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
543,196
shares
|
$10.7 Million
0.0% of portfolio
|
Q2 2025
Added 186.38%
|
|
|
Wildcat Capital Management, LLC
|
Jul 18, 2025 Q2 2025 |
495,606
shares
|
$9.79 Million
4.47% of portfolio
|
Q2 2023
New holding
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
484,823
shares
|
$9.58 Million
0.0% of portfolio
|
Q2 2025
Added 426.84%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
478,400
shares
|
$9.45 Million
0.23% of portfolio
|
Q2 2025
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
470,726
shares
|
$9.3 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.55%
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
384,891
shares
|
$7.6 Million
0.0% of portfolio
|
Q2 2025
Added 1214.65%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
370,959
shares
|
$7.33 Million
0.0% of portfolio
|
Q1 2025
Added 1656.93%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
361,441
shares
|
$7.14 Million
0.0% of portfolio
|
Q2 2025
Reduced 1.96%
|